8-K
filed May 1, 2026, 7:59 PM ET
ticker DMAA
CIK 0002028614
other material
confidence high
sentiment neutral
materiality 0.85
SPAC DMAA shareholders approve extension to April 2027; ~28% of shares redeemed for $99.3M
Drugs Made In America Acquisition Corp.
- Extension proposal approved: 18,906,281 for, 4,892,646 against, 0 abstain.
- Combination period extended up to 12 months to April 29, 2027 with monthly deposits of ~$300k.
- Redemption of 9,440,230 shares at ~$10.52/share, removing $99,336,016.67 from trust account.
- Post-redemption shares outstanding: 24,276,913 (13,559,770 from IPO).
- Board approved initial one-month extension to May 29, 2026.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-051018
- form_type
- 8-K
- ticker
- DMAA
- cik
- 0002028614
- company_name
- Drugs Made In America Acquisition Corp.
- filed_at
- 2026-05-01T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.408679+00:00
- generated_at
- 2026-05-15T00:24:20.568899+00:00
- sec_items
- ["5.03", "5.07", "8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-051018
- json_url
- https://secwatch.observer/filing/0001213900-26-051018.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-051018.md
- text_url
- https://secwatch.observer/filing/0001213900-26-051018.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/0001213900-26-051018-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/ea0288774-8k_drugs.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.
Filing page
SEC filing
ADT
Apollo sells all 102M ADT shares; ADT repurchases 29.1M shares in $1.5B plan
ADT Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
On May 8, 2026, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws, dated as of September 15, 2023 (as amended, the “ Bylaws ”), to remove references related to Apollo and the Amended and Restated Stockholders Agreement, dated December 14, 2018, between the Company, Prime Security Services TopCo Parent, L.P., and the Co-Investors.
Filing page
SEC filing
QLEP
Quantum Leap Acquisition Corp closes $200M SPAC IPO on NYSE
Quantum Leap Acquisition Corp
May 6, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
In connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies. The Amended and Restated Memorandum and Articles of Association have an effective date of April 29, 2026, being the date on which the special resolution to adopt the Amended and Restated Memorandum and Articles of Association was passed.
Filing page
SEC filing
MCAH
Mountain Crest Acquisition 6 Corp. closes $60M IPO; units start trading April 30
Mountain Crest Acquisition 6 Corp.
May 5, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
On April 29, 2026, in connection with the IPO, the Company filed its Amended and Restated Memorandum and Articles of Association, as described in the Registration Statement, with the Registry of Corporate Affairs of British Virgin Islands.
Filing page
SEC filing
MRKR
Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M
Marker Therapeutics, Inc.
May 4, 2026, 7:59 PM ET
other_material
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of our Common Stock from 30,000,000 shares of Common Stock to 130,000,000 shares of Common Stock (the “ Charter Amendment ”).
Filing page
SEC filing
COAG
Hemab Therapeutics completes IPO of 19.3M shares at $18.00, raising $346.7M
Hemab Therapeutics Holdings, Inc.
May 4, 2026, 7:59 PM ET
other_material
Items 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
On May 4, 2026, Hemab Therapeutics Holdings, Inc. (the “Company”) filed a restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the closing of the Company’s initial public offering of common stock (the “IPO”).
Filing page
SEC filing
CWEN
Clearway Energy eliminates Class A stock; converts all shares to reduced-vote Class C
Clearway Energy, Inc.
May 1, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 5.07, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
Following the Class A Conversion, on May 1, 2026, the Company filed with the Delaware Secretary of State a certificate of retirement pursuant to Section 243 of the DGCL (the “Certificate of Retirement”) to retire all shares of Class A common stock converted in the Class A Conversion, which also had the effect of amending the Amended Charter to (i) reduce the total number of authorized shares of Class A common stock from 34,613,853 to zero, (ii) reduce the total number of authorized shares of capital stock of the Company from 2,544,613,853 to 2,510,000,000 and (iii) eliminate from the Amended Charter all references to the Class A common stock (collectively, the “Class A Retirement”).
Filing page
SEC filing
RREV
RRE Ventures Acquisition Corp. prices and closes $250M IPO; units begin trading on Nasdaq
RRE Ventures Acquisition Corp.
May 1, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month
Comparable filing
On April 28, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 29, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.